Evidence map›Paper›PMID 32565471›Full record

ArticleBMJ open2020

How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study.

Niina Mononen, Marika Pohjanoksa-Mäntylä, Marja Sa Airaksinen, Katri Hämeen-Anttila

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Niina MononenDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland niina.mononen@helsinki.fi.ORCID 0000-0001-7846-3492
Marika Pohjanoksa-MäntyläDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Marja Sa AiraksinenDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Katri Hämeen-AnttilaAssessment of Pharmacotherapies, Finnish Medicines Agency Fimea, Helsinki, Finland.
University of Helsinki · FIFinnish Medicines Agency Fimea · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFinland is one of the few countries that has established a national Medicines Information (MI) Strategy. The ultimate goal of the strategy is a well-implemented medication use process resulting in well-informed adherent patients. This study aimed at evaluating the implementation of the strategy 3 years after its launch.

designThe evaluation applied a pragmatic approach and was conducted by interviewing stakeholders involved in the National MI Network enhancing the MI Strategy's implementation. The network comprises national key stakeholders producing and using MI. Data were deductively analysed according to the medication use process of the MI Strategy using the framework method, complemented with inductively derived categories.

settingNational implementation of the MI Strategy throughout the healthcare system after the first operational period (2012-2014) in 2015.

participantsThe members of the National MI Network (n=79/111, participation rate 71%, representing 42/53 stakeholder organisations). OUTCOME MEASURES: A new conceptual framework was developed based on stakeholders' views on well-implemented actions and actions needing development in the medication use process at (1) infrastructure (

resultsMedication counselling by community pharmacists was the primary implemented action, followed by physicians' actions while starting a new medication, and advice given by nurses. The major development needs concerned (1) poor access to patient information and its transfer in healthcare, particularly the lack of reconciled medication lists and electronic health records (

conclusionsFar more actions for development than well-established practices in the medication use process were identified. Major challenges found in this evaluation are considered in the ongoing Rational Pharmacotherapy Action Plan 2018-2022 by the Ministry of Social Affairs and Health.

Indexed as

CounselingDrug Information ServicesMedication AdherenceAccess to InformationCross-Sectional StudiesFemaleFinlandHumansMaleMedication ReconciliationNursesPharmacistsStakeholder Participationhealth policyhealth services administration & managementorganisation of health servicespublic healthqualitative research

Identifiers

PMID32565471
PMCPMC7307543
OpenAlexW3036242063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.